The ever-increasing demand for enantiopure drugs and agrochemicals, and the use of chiral building blocks in polymers, liquid crystals, and other materials has generated a strong stimulus for the development of asymmetric methods that utilize previously unexplored starting materials to generate efficient access to new and emerging target compounds.[1] New drug candidates that bear a chiral 1, 3-diaminopropanol moiety or a corresponding ...
